Needle in a haystack

New England Journal of Medicine

Volumn 354, Issue 1, 2006, Pages 68-73

  Polu, Krishna R ^a   Wolf, Myles ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; CREATININE;

ABDOMINAL AORTA; ADULT; ANXIETY DISORDER; AORTA ATHEROSCLEROSIS; ARTICLE; BORDERLINE HYPERTENSION; CARDIOMEGALY; CASE REPORT; DEPRESSION; DYSPNEA; ECHOGRAPHY; HEMODIALYSIS; HORSESHOE KIDNEY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EDEMA; LUNG EMBOLISM; LUNG INFILTRATE; MAGNETIC RESONANCE ANGIOGRAPHY; MAINTENANCE THERAPY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTHROMBIN TIME; THORAX RADIOGRAPHY; UREMIA; URINALYSIS; BLOOD; CACHEXIA; CONGENITAL MALFORMATION; FAT EMBOLISM; KIDNEY; KIDNEY DISEASE; LUNG; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RENAL ARTERY;

CACHEXIA; CREATININE; DYSPNEA; EMBOLISM, CHOLESTEROL; HUMANS; KIDNEY; KIDNEY DISEASES; LUNG; MALE; MIDDLE AGED; PULMONARY EDEMA; PULMONARY EMBOLISM; RENAL ARTERY;

EID: 30044446242     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcps051939     Document Type: Article

References (11)

1. Moll S, Huffman J. Cholesterol emboli associated with warfarin treatment. Am J Hematol 2004;77:194-5.
2. Wong FK, Chan SK, Ing TS, Li CS. Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am J Kidney Dis 1995;26:508-10.
3. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med 1996;100:524-9.
4. Thadhani RI, Camargo CA Jr, Xavier RJ, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Medicine 1995;74:350-8.
5. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003;14:1584-90.
6. Espejo B, Herrero JC, Torres A, et al. Immunoallergic interstitial nephritis vs. cholesterol atheroembolism: differentiating characteristics. Nefrologia 2003;23:125-30. (In Spanish.)
7. Scolari F, Tardanico R, Pola A, et al. Cholesterol crystal embolic disease in renal allografts. J Nephrol 2003;16:139-43.
8. Goldman M, Thoua Y, Dhaene M, Toussaint C. Necrotising glomerulonephritis associated with cholesterol microemboli. BMJ 1985;290:205-6.
9. Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000;36:1089-109.
10. Liss KA, Gaughan WJ, McCue PA, Burke JF. Coexistence of atheroemboli and minimal-change disease. Clin Nephrol 1997;47:125-8.
11. Greenberg A, Bastacky SI, Iqbal A, Borochovitz D, Johnson JP. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations. Am J Kidney Dis 1997;29:334-44.